RXR antagonist 1（Cat No.:I043890）is a selective inhibitor targeting the retinoid X receptors (RXRs), which are involved in regulating gene expression related to cellular differentiation, growth, and metabolism. RXRs form heterodimers with other nuclear receptors and influence a variety of biological processes, including lipid metabolism, immune response, and cell proliferation. By blocking RXR activation, RXR antagonist 1 can potentially modulate these pathways, making it a promising candidate for treating conditions like cancer, metabolic disorders, and inflammatory diseases. Its therapeutic potential lies in selectively disrupting RXR-driven signaling without affecting other receptor pathways.